Evaluation of HIV-1 Immunogen, an Immunologic Modifier, Administered to Patients Infected With HIV Having 300 to 549 × 10

Incorrect Text. In the Original Contribution entitled "Evaluation of HIV-1 Immunogen, an Immunologic Modifier, Administered to Patients Infected With HIV Having 300 to 549 × 10⁶/L CD4 Cell Counts: A Randomized Controlled Trial" published in the November 1, 2000, issue of THE JOURNAL (2000;284:2193-2202), errors occurred on pages 2195, 2197, and 2202. On page 2195, column 3, the second to last sentence in the full paragraph should be: "The IRC performed all lymphocyte proliferation assays and contracted with an independent laboratory to perform viral load assays." In the first paragraph of the "Results" section on page 2197, the following sentence has been corrected because of an incorrect percentage: "At the time of randomization, 27% of the subjects were not receiving ART, 5% were receiving monotherapy, and 68% were receiving combination ART (31% of the total population were receiving a PI)." On page 2202, the second sentence in the second column should be: "In addition, we could not obtain an updated list of the site coinvestigators who participated in the trial so that the manuscript could be shared with them and they could be acknowledged for their efforts."